INSM - Episodic Pivot - 2025-06-15
INSM Trade Summary
Performance metrics and trade details for INSM breakout.
- Stage
- 1
- Catalyst
- New Product
- Risk
- 3.0%
- Gain %
- 19.0%
- Market Condition
- Choppy
- Entry
- OPB
- Stop
- LoD
- Reward Risk Ratio
- 6.3R
- About
On June 10th (pre-market), Insmed (INSM) announced positive results from its Phase 2b study of treprostinil palmitil inhalation powder (TPIP) as a once-daily therapy for patients with pulmonary arterial hypertension. The stock reacted sharply to the news, gapping up approximately 25%.
Leading up to this catalyst, INSM had been trading sideways for about a year, forming a flat Darvas box base—indicating a period of consolidation and accumulation. The strong clinical data served as a breakout trigger from this base, marking a potential shift in trend driven by a significant product development milestone.
Before Breakout Weekly
Before Breakout Daily
Intraday Entry
After Breakout
Market Correlation Analysis for INSM
Top Similar Tickers
Stocks that move in the same direction as INSM
| Rank | Ticker | Score |
|---|---|---|
| No similar stocks found in the current universe. | ||
Top Inverse Tickers
Stocks that move opposite to INSM
| Rank | Ticker | Score |
|---|---|---|
| No inverse stocks found in the current universe. | ||